Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

US FDA’s Abernethy Leaves Behind Legacy Of Tech Modernization, Real-World Data

Mar 24 2021

• By Sue Sutter

Related Content

Pandemic Accelerates US FDA’s Use Of Real-World Data From Clinical Trial Design To Supply Chain

Jan 23 2021

US FDA Taps Abernethy As Principal Deputy Commissioner; Health IT Exec Brings “Real-World” Expertise

Dec 17 2018

Real-World Evidence On COVID-19: US FDA Approaching With 'Sense Of Urgency'

Apr 22 2020

US FDA's Abernethy 'Cautious' About Real-World Evidence

Aug 07 2019

US FDA IT Modernization Plan Will Lay Groundwork For Real-Time Data Submissions

Sep 22 2019

FDA Launches Digital Modernization Plan To Complement Its Technology Modernization Plan

Mar 04 2021

Gottlieb: No ‘Plan B’ If Woodcock Isn’t Nominated As US FDA Commissioner

Mar 24 2021

Related Companies

Flatiron Health Inc.

Additional Topics

International United States US States FDA Leadership Regulation Cosmetics Coronavirus COVID-19 Dietary Supplements Enforcement Manufacturing OTC Drugs Policy Politics Consumer

More from Regulation

More from Policy & Regulation

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window